Recall: D-0684-2018

Class II - Potentially Harmful

Class IIClassification

2018-03-27Initiated

TerminatedStatus

Lupin Pharmaceuticals Inc.Firm

Product

Lupin Cefdinir powder for Oral Suspension USP, 250 mg/5 mL in (a) 60 mL packs ( NDC 68180-723-20) and (b) 100 mL packs ( 68180-723-10), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202

Reason

Superpotent Drug

Distribution

Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.